chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have felt extremely weak and fatigued since i got my First dose. It has not subsided at all and it's been 8 days. I feel shaky and get hot flushing every time I exert myself. I feel like I have the flu.
I had a sore arm for about a day after receiving the vaccine. I tested positive for COVID-19 on 05/05/2023.  I had a sore throat, fatigue, runny nose and congestion. I contacted my doctor and got a prescription for Paxlovid. I had diarrhea and bad taste in my mouth while taking the medication. I still have a runny nose and I clear my throat all day. I am seeing an ENT today for possible sinus infection diagnosis.
Swollen lymph nodes under left arm, left breast pain and discomfort lasting 3 weeks ( still ongoing). Swollen lymph nodes around neck.
Patient stated she broke out in a rash on her back 3 days after receiving first dose.  It lasted for 10 days.  She had no other symptoms.
Died of Covid; Got pneumonia as well; Got bronchitis; Flu shot / her / health declined after that; got sick for over a year now; This case was reported by a consumer via other manufacturer and described the occurrence of covid-19 in a elderly female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   Concurrent medical conditions included low blood pressure.   In November 2019, the patient received Influenza vaccine Quadrivalent 2019-2020 season. On an unknown date, less than 2 years after receiving Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced covid-19 (serious criteria death), pneumonia (serious criteria GSK medically significant), bronchitis, general physical health deterioration and sickness. On an unknown date, the outcome of the covid-19 was fatal and the outcome of the pneumonia, bronchitis, general physical health deterioration and sickness were unknown. The reported cause of death was covid-19.   It was unknown if the reporter considered the covid-19, pneumonia, bronchitis, general physical health deterioration and sickness to be related to Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: The case was reported by patient's daughter. The age at vaccination was not reported. In 2019, the patient received Flu vaccine and got bronchitis, and pneumonia as well and ever since she got sick for over a year. The patient's health declined after that. The patient was elderly, so the reporter was very careful in following up on protocol. The reporter stated that the patient died of Covid. The reporter consented to follow up. This is 1 of 3 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR095136:Same reporter US-GLAXOSMITHKLINE-US2021AMR095203:Same reporter. Flu shot reporter's case.; Reported Cause(s) of Death: COVID-19
symptoms began within 12 hrs after receiving injection.  Beginning with muscle soreness at site of injection, hot to the touch,  I could not touch  the area without pain.  If I rolled onto my left side, I was awakened.  Next phase was body aches and extreme exhaustion.  I felt as if all life had been drained of me, and THESE symptoms were to recycle and continue for a period of 7 days,  Today,  being my first day of stability and feeling of ability to function.   Over the course of these 7 days, I've felt  lightheadedness, loss of appetite, and extreme  & ongoing exhaustion was pervasive. My injection site has improved in pain at about the 5th day.    My concern and reason for this notification is that I have never had symptoms for anything,  last and continue on a re-occurring  basis, for a period of 7 days.    Finally today (7 days later) I am feeling a return to "life".      wow.
Patient came in for prenatal care at the OB/GYN department. According to OB/GYN provider assessment patient's last menstrual period was on 11/28/18 and patient received Varicella vaccine on 12/19/2018 at her primary care's office at another facility. Patient's estimated date of delivery is 09/04/2019.
onset of generalized urticaria @ 18hrs p/vax; DPH given w/relief of hives
Patient inadvertently was given 3rd dose of COVID vaccine. No other adverse effects noted at this time.
Started having increased Osteoarthritis pain and stiffness in my joints; Mainly in my knees, hips, ankles, back, pelvis and SI joints; is worse on my left side. Along with past tests am having a Colonoscopy on 12/2/2022.
About 5 minutes after receiving vaccine patient turned pale and leaned back into her chair and began having convulsions. this lasted for about 20 seconds and 911 was called.  Paramedics advised patient to go to the emergency room for further evaluation. patient stated she has had a history of seizures.
28 y/o male with hx of papular rash starting after receiving 2nd dose of Moderna Covid 19 vaccine. Rash located to the bilateral chest and around the left cheek and eye. No hive, no urticaria, no angioedema
I had ammonia smell or a strong smell through my noise and was just sitting in my living room. Later that night about 12:00 pm I had itching all over my legs and upper torso along with the chills very bad. I took a Zartac for the itching. In the morning if felt washed out and aches and pains. I took 2 tylennol. This seemed to help.  By 12:00pm that day I was feeling better.
Moderate COVID-19 Vaccine EUA On Friday 1-22-21 my left arm below injection site became very red hot and painful, I also felt like I had the flu, body aches and fever. It did not improve so I was seen by my PCP today 1-25-21 and diagnosed with an arm infection. I was started on  doxycycline 1 twice a day for 7 days and told to use ice and ibuprofen.
swollen face; swollen tongue; rare allergic reaction; itchy; rashes on her entire torso / legs, back, neck and hands / stomach and forearms; throat closed; could not swallow; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included prednisone unknown for product used for unknown indication.   On 17th November 2021 11:00, the patient received the 1st dose of Shingrix. On 18th November 2021, the patient started prednisone 40 mg at an unknown frequency. On an unknown date, the dose was changed to 20 mg at an unknown frequency. On 9th October 2021, the dose was changed to 10 mg at an unknown frequency. On 17th November 2021, less than an hour after receiving Shingrix, the patient experienced allergic reaction, pruritus, generalized rash, throat constriction and unable to swallow. On 21st November 2021, the patient experienced facial swelling and swollen tongue. The patient was treated with benadryl (nos) (Benadryl) and steroids nos (Steroid (Not Specified)). The action taken with prednisone was unknown. On an unknown date, the outcome of the allergic reaction, throat constriction, unable to swallow, facial swelling and swollen tongue were unknown and the outcome of the pruritus was recovered/resolved and the outcome of the generalized rash was not recovered/not resolved.   It was unknown if the reporter considered the allergic reaction, pruritus, generalized rash, throat constriction, unable to swallow, facial swelling and swollen tongue to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. The patient received the first dose of Shingrix and within an hour, she started feeling itchy.  Four hours after she received the vaccine she was covered in rashes on her entire torso. Rash was also seen on her legs, back, neck and hands.  Later that night, her throat closed and she could not swallow.  She stated that she went to the emergency room in the morning of 18th November 2021 where she was given 40 mg prednisone.  3 days later, she experienced a swollen face and swollen tongue.  Her doctor gave her a large dose of steroid (name unknown).  She had been taking 20 mg prednisone for the last week and she took 10mg prednisone yesterday.  She had also been using Benadryl on her rashes to help treat it.  She was still experiencing rash which was seen on her stomach and forearms.  The patient also had a rare allergic reaction. Emergency room visit was required. It was unknown if the reporter considered the allergic reaction, pruritus, generalized rash, throat constriction, unable to swallow, facial swelling and swollen tongue to be related to Prednisone. The reporter consented to follow up.
This spontaneous report as received from a registered nurse, refers to a patient of unknown gender and age. The patient's concurrent conditions and medical history were not reported. On 13-FEB-2017, the patient inadvertently received an expired dose of ZOSTAVAX (dosage, anatomical location and route of administration were not reported), lot # L044528, expiration date: 09-FEB-2017, for prophylaxis. No information about concomitant therapies was provided. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
I woke up early in am (2:35am) with terrible bone pain, joint pain, it hurt to MOVE.  My pain level was 8 out of 10.  When I tried to get out of bed, I was dizzy and had to hold to the walls to make it to the bathroom.  I had severe dry mouth, nausea, muscle weakness, loss of appetite and chills.  I was unable to go to work.  The symptoms did not begin to subside until later in the evening the next day around 6:30pm.  Today I am still weak but making it.  Still having chills, and some minor muscle aches and spasms.
This is a spontaneous report from a contactable pharmacist received via a  Pfizer sales representative. A 60-year-old female patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration in Apr2015 as single dose for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced deltoid swollen post vaccination in Apr2015; the event was reported as deltoid was swollen for three to four days post vaccination. The outcome of deltoid swollen post vaccination was recovered on an unspecified date in 2015.
This spontaneous report as received from a physician refers to a 17 week old female patient. on 18-FEB-2014 the patient was vaccinated with the first dose of ROTATEQ, (lot#, expiry date, dose and route not reported) for vaccination. The physician reported that within 48 hours of receiving the first dose of ROTATEQ (dose, route, lot#, expiry date unspecified), also reported as 21-OCT-2013, the patient developed what was believed to be rotavirus gastroenteritis. The physician reported that the patient had many (8 to 10) white "cheesy" stools a day. The outcome of the events was reported as not recovered. The patient had sought medical attention by contacting office. Additional information has been requested.
I had fever, body aches, fatigue, cough, and infrequent headaches which only lasted for about 5 days i was prescribed the antiviral medications Paxlovid for my symptoms.
48 hrs after  2nd dose experienced tingling in my breast; when pressed on both breast i can express milk like discharge; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL) started at unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 30Mar2021 as a single dose for COVID-19 immunisation. The patient had no known allergies. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Apr2021 at 12:00, exactly 48 hours after second dose, the patient experienced, tingling in breast and when pressed on both breast express milk like discharge. The patient reported that exactly 48 hours after 2nd dose the patient experienced tingling in breast (same as would feel when breastfeeding) and since then when pressed on both breast the patient could express milk like discharge and the patient had not breastfeed for 5 years at the time of report. It was unknown whether any therapeutic measures were taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling in breast and when pressed on both breast express milk like discharge was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
The evening following admin of vax pt awoke w/a scream-type cry, shaking, pale in color & seemed to have no muscle control; pt could not sit up; pt very hot to touch & eyes not focusing; taken to MD, ear infect dx & ATB prescribed;
Localized swelling with formation of large, well circumscribed mass and associated pain (Adacel)
The booster dose was given 6 days early to the recommended 5 month interval from completion of initial series.
I was not able to lift my left arm at all after my vaccine. Slowly over time I began to regain some mobility. It took a year to regain full mobility.
pt recvd vax & had localized swelling & erythema at LA 6.5 x 10cm;
Information has been received from a physician concerning a 9 year old female patient who on 03-JAN-2002 was vaccinated with the first dose of MMR II. The patient received the second dose of MMR II on 09-NOV-2004. On 08-JAN-2010, the patient experienced mumps. The date diagnosed was reported as 10-JAN-2010. The patient was afebrile and had left parotitis. The outcome for mumps was not reported. No further information is available.
79 y/o female, BMI 35, PMHx of aortic valve disorder, Bell's palsy, CVA, HTN, DM, hypercholesterolemia, thoracic aortic aneurysm, pacemaker, thyroid disorder, fatty liver, admitted for SOB on 9/18/21. Chest x-ray shows bilateral interstitial and groundglass airspace opacities. Acute hypoxia secondary to Covid treated with oxygen supplementation. Supportive care give. Pt discharged back to nursing home on 9/18/21 in the evening.
The patient developed a low fever a day after the second dose of vaccination.  The fever lasted for a day.; The patient continued to feel fatigue for six days.; This is a spontaneous report from a contactable consumer. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Feb2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 20Feb2021, the patient experienced a low fever a day after the second dose of vaccination. The fever lasted for a day. The patient continued to feel fatigue for six days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown if the patient received any treatment for the events. The clinical outcome of the event a low fever after the second dose of vaccination recovered on 21Feb2021. While that of felt fatigue was recovered on 26Feb2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.
No adverse event; Improperly stored vaccine; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided.  On 17-NOV-2020, the patient was vaccinated with an improperly stored dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot # R034547, which was confirmed to be a valid lot number, expiration date: 09-JUN-2021) at a dose of 0.5 milliliter for prophylaxis (route of administration, vaccination scheme frequency, anatomical location were not reported). The administered dose of the vaccine experienced a temperature excursion 46.9 degrees Fahrenheit (F) for 15 minutes, as recorded by a data logger. There was no adverse effect reported.
Welt on arm next to site where shot was given.  Headache, stomach, achy, tired
This case was reported by a pharmacist via call center representative and described the occurrence of suspected vaccination failure in an unspecified number of patients who received FLUARIX QUADRIVALENT 2018-2019 season for prophylaxis. On an unknown date, the patients received FLUARIX QUADRIVALENT 2018-2019 season at an unknown dose. On an unknown date, less than a year after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patients experienced vaccination failure (serious criteria GSK medically significant) and h1n1 influenza. On an unknown date, the outcome of the vaccination failure and h1n1 influenza were unknown. It was unknown if the reporter considered the vaccination failure and h1n1 influenza to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional information received as follows: The age at vaccination was not applicable for this report. The pharmacist stated that they vaccinated patients with FLUARIX QIV 2018-2019 year and many of the patients got the flu caused by H1N1 strain. However, the healthcare professional did not have the specific strain of H1N1 just that the influenza virus some patients contracted was from H1N1 (but healthcare professional did not have the specific H1N1 strains of flu these patients got). The healthcare professional unsure if a lack of effect from FLUARIX, or if the H1N1 strain of influenza these patients contracted was not contained in 2018-2019 years flu vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and time to onset for flu was not provided. The reporter did not consent to follow-up. Lab Comments: On an unknown date the patients were positive for H1N1 strain of influenza.
PATIENT IMMEDIATELY DEVELOPED RASH,  STATED HEART WAS RACING AND NUMBNESS DOWN LEGS.  CALLED EMS AND PATIENT WAS EVALUATED BY EMS. EMS CLEARED PATIENT TO GO HOME AND FOLLOW UP WITH PROVIDER AS SHE WAS 'STABLE' AND HAD NO DIFFICULTY BREATHING OR WORSENING SYMPTOMS.  PT WILL FOLLOW UP WITH PCP.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug allergies or reactions were not reported. On 29-OCT-2014, the patient was vaccinated with a dose of (Oka/Merck) PROQUAD lot # K009894, expiry date: 11-JAN-2016 (dose and route were not reported) that underwent temperature excursion. Concomitant medication was not reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested
Information has been received from a consumer concerning her 14 year old daughter who on 12-FEB-2007 was vaccinated with Gardasil (lot # not reported)  0.5 ml IM. There was no concomitant medication. On 12-FEB-2007 the patient experienced her arm hurting really bad after getting the injection and she developed a headache. Three days after the injection, on 15-FEB-2007, the patient experienced fainting, dizziness, headaches, "dehydrating", not eating, everything kind of hurts, and she only wanted to sleep. Her blood pressure was not steady and was all over the place. Medical attention was sought. Orthostatic test was performed. At the time of reporting, the patient had not recovered. Additional information has been requested.
Systemic: Seizure-Mild, Additional Details: Seizure monitored by husband and lasted approx 30 minutes. The seizure subsided before EMS arrived and patient sent them away without receiving additional evaluation. I advised the patient to seek additional medical evaluation from their PCP to determine if there may have been another cause for this event.
This case was reported by a physician via sales rep and described the occurrence of macular rash in a 20-year-old male patient who received BEXSERO. On an unknown date, the patient received BEXSERO. On an unknown date, 12 days after receiving BEXSERO, the patient experienced macular rash, erythematous rash, itchy rash, patchy rash and injection site pain. On an unknown date, the outcome of the macular rash, erythematous rash, itchy rash, patchy rash and injection site pain were recovered/resolved. It was unknown if the reporter considered the macular rash, erythematous rash, itchy rash, patchy rash and injection site pain to be related to BEXSERO. Additional details were reported as follows: The patient experienced a rash on his limbs and half of his waist, which was described as a fine, macular, pink rash that was hard to see. The rash was mildly itchy. The rash presented as scant patches scattered on patient's limbs and half of his waist. The patient also experienced soreness at the injection site on his arm that lasted approximately a week. There were no other adverse events reported. The patient received the vaccine somewhere other than the student health center. The patient sought treatment at the health center by Nurse Practitioner. The nurse reported it to the MD who reported it to the GlaxoSmithKline field rep. The physician reported that the rash presented for care 13 days later with a rash that was already resolving. The rash was almost completely resolved one day after it presented. The date of administration and the batch number was unknown. The patient slept on a friend's futon 2 days before the rash presented. The parts of the patient's body that were covered by clothing did not show the rash. The field representative attempted to report it to the facility yesterday but the center was closed. The nursing professional said she would report it to VAERS.
Still diagnosed with COVID 19; Still diagnosed with COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): ID (manufacturer).  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Aug2022, outcome "unknown" and all described as "Still diagnosed with COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.